查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1742554

藥物洗脫支架市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Drug-Eluting Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 205 Pages | 商品交期: 2-10個工作天內

價格

藥物洗脫支架市場-報告範圍

TMR 的全球藥物洗脫支架市場報告研究了過去和當前的成長趨勢及機遇，旨在深入了解 2025 年至 2035 年預測期內的市場指標。該報告提供了 2019 年至 2035 年期間全球藥物洗脫支架市場的收入，以 2025 年為基準年，2035 年為預測年。該報告還提供了 2025 年至 2035 年全球藥物洗脫支架市場的年複合成長率(CAGR%)。

本報告經過廣泛的調查後編寫。主要研究工作包括分析師對關鍵意見領袖、產業領袖和輿論領袖的訪談。次要研究則參考了主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解藥物洗脫支架市場。

市場概況
2024 年的市場價值 77億美元
2035年的市場價值 142億美元
複合年成長率 5.7%

本報告深入探討了全球藥物洗脫支架市場的競爭格局。報告確定了全球藥物洗脫支架市場的主要參與者，並根據其各項屬性進行了分析。本報告對全球藥物洗脫支架市場參與者的屬性進行了分析，內容包括公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2035年全球藥物洗脫支架市場分析與預測

第5章：關鍵見解

  • 技術進步
  • 波特五力分析
  • PESTEL分析
  • 供應鏈分析
  • 重要產業事件（合併、收購、合作、協作等）
  • 定價分析（品牌定價、按地區/國家分類的平均售價）
  • 各主要國家的監管情況
  • 研發趨勢
  • 新市場進入者的市場進入策略

第6章：全球市場分析與預測：依材料

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按材料，2020-2035
    • 金屬
      • 不銹鋼
      • 鈷鉻合金
      • 鎳鈦合金
      • 其他
    • 聚合物
      • 非生物分解的聚合物
      • 可生物分解聚合物
  • 市場吸引力分析：按材料

第7章：全球市場分析與預測：按藥物

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按藥物，2020-2035
    • 雷帕黴素
    • 紫杉醇
    • 佐他莫司
    • 依維莫司
    • 其他
  • 市場吸引力分析：按藥物

第8章：全球市場分析與預測：按應用

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按應用，2020-2035
    • 冠狀動脈疾病
    • 周邊動脈疾病
    • 其他
  • 市場吸引力分析：按應用

第9章：全球市場分析與預測：按最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2020-2035
    • 醫院
    • 門診手術中心
    • 其他
  • 市場吸引力分析：按最終用戶

第10章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2035
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第 11 章：北美市場分析與預測

第12章：歐洲市場分析與預測

第14章：拉丁美洲市場分析與預測

第15章：中東與非洲市場分析與預測

第 16 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2024年）
  • 公司簡介
    • Abbott Laboratories
    • AlviMedica
    • B. Braun Melsungen AG
    • Biosensors International Group, Ltd.
    • Shandong JW Medical Systems LTD.
    • Boston Scientific Corporation
    • Cook Medical Inc.
    • Elixir Medical Corp.
    • Lepu Medical Technology (Beijing) Co., Ltd.
    • Medtronic plc
    • Eurocor GmbH
    • OrbusNeich Medical Company Limited
    • Shanghai MicroPort Medical Co., Ltd.
    • Sino Medical Sciences Technology Inc.
Product Code: TMRGL30632

Drug-Eluting Stents Market - Scope of Report

TMR's report on the global drug-eluting stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug-eluting stents market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug-eluting stents market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug-eluting stents market.

Market Snapshot
Market Value in 2024US$ 7.7 Bn
Market Value in 2035US$ 14.2 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug-eluting stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug-eluting stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug-eluting stents market.

The report delves into the competitive landscape of the global drug-eluting stents market. Key players operating in the global drug-eluting stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug-eluting stents market profiled in this report.

Key Questions Answered in global drug-eluting stents Market Report:

  • What is the sales/revenue generated by drug-eluting stents across all regions during the forecast period?
  • What are the opportunities in the global drug-eluting stents market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug-Eluting Stents Market - Research Objectives and Research Approach

The comprehensive report on the global drug-eluting stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug-eluting stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug-eluting stents market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug-Eluting Stents Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug-Eluting Stents Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
  • 5.7. Regulatory Scenario by Key Country/Region
  • 5.8. Research and Development Trends
  • 5.9. Go-to-Market Strategy for New Market Entrants

6. Global Drug-Eluting Stents Market Analysis and Forecast, by Material

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Material, 2020-2035
    • 6.3.1. Metal
      • 6.3.1.1. Stainless-Steel
      • 6.3.1.2. Cobalt-Chromium
      • 6.3.1.3. Nitinol
      • 6.3.1.4. Others
    • 6.3.2. Polymer
      • 6.3.2.1. Non-biodegradable Polymers
      • 6.3.2.2. Biodegradable Polymers
  • 6.4. Market Attractiveness Analysis, by Material

7. Global Drug-Eluting Stents Market Analysis and Forecast, by Drug

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug, 2020-2035
    • 7.3.1. Sirolimus
    • 7.3.2. Paclitaxel
    • 7.3.3. Zotarolimus
    • 7.3.4. Everolimus
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Drug

8. Global Drug-Eluting Stents Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application , 2020-2035
    • 8.3.1. Coronary Artery Disease
    • 8.3.2. Peripheral Artery Disease
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Drug-Eluting Stents Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2035
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Drug-Eluting Stents Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Drug-Eluting Stents Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Material, 2020-2035
    • 11.2.1. Metal
      • 11.2.1.1. Stainless-Steel
      • 11.2.1.2. Cobalt-Chromium
      • 11.2.1.3. Nitinol
      • 11.2.1.4. Others
    • 11.2.2. Polymer
      • 11.2.2.1. Non-biodegradable Polymers
      • 11.2.2.2. Biodegradable Polymers
  • 11.3. Market Value Forecast, by Drug, 2020-2035
    • 11.3.1. Sirolimus
    • 11.3.2. Paclitaxel
    • 11.3.3. Zotarolimus
    • 11.3.4. Everolimus
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Application , 2020-2035
    • 11.4.1. Coronary Artery Disease
    • 11.4.2. Peripheral Artery Disease
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2020-2035
    • 11.5.1. Hospitals
    • 11.5.2. Ambulatory Surgical Centers
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2020-2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Material
    • 11.7.2. By Drug
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Drug-Eluting Stents Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Material, 2020-2035
    • 12.2.1. Metal
      • 12.2.1.1. Stainless-Steel
      • 12.2.1.2. Cobalt-Chromium
      • 12.2.1.3. Nitinol
      • 12.2.1.4. Others
    • 12.2.2. Polymer
      • 12.2.2.1. Non-biodegradable Polymers
      • 12.2.2.2. Biodegradable Polymers
  • 12.3. Market Value Forecast, by Drug, 2020-2035
    • 12.3.1. Sirolimus
    • 12.3.2. Paclitaxel
    • 12.3.3. Zotarolimus
    • 12.3.4. Everolimus
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Application , 2020-2035
    • 12.4.1. Coronary Artery Disease
    • 12.4.2. Peripheral Artery Disease
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2020-2035
    • 12.5.1. Hospitals
    • 12.5.2. Ambulatory Surgical Centers
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Material
    • 12.7.2. By Drug
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Drug-Eluting Stents Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Material, 2020-2035
    • 13.2.1. Metal
      • 13.2.1.1. Stainless-Steel
      • 13.2.1.2. Cobalt-Chromium
      • 13.2.1.3. Nitinol
      • 13.2.1.4. Others
    • 13.2.2. Polymer
      • 13.2.2.1. Non-biodegradable Polymers
      • 13.2.2.2. Biodegradable Polymers
  • 13.3. Market Value Forecast, by Drug, 2020-2035
    • 13.3.1. Sirolimus
    • 13.3.2. Paclitaxel
    • 13.3.3. Zotarolimus
    • 13.3.4. Everolimus
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Application , 2020-2035
    • 13.4.1. Coronary Artery Disease
    • 13.4.2. Peripheral Artery Disease
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2020-2035
    • 13.5.1. Hospitals
    • 13.5.2. Ambulatory Surgical Centers
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Material
    • 13.7.2. By Drug
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Drug-Eluting Stents Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Material, 2020-2035
    • 14.2.1. Metal
      • 14.2.1.1. Stainless-Steel
      • 14.2.1.2. Cobalt-Chromium
      • 14.2.1.3. Nitinol
      • 14.2.1.4. Others
    • 14.2.2. Polymer
      • 14.2.2.1. Non-biodegradable Polymers
      • 14.2.2.2. Biodegradable Polymers
  • 14.3. Market Value Forecast, by Drug, 2020-2035
    • 14.3.1. Sirolimus
    • 14.3.2. Paclitaxel
    • 14.3.3. Zotarolimus
    • 14.3.4. Everolimus
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Application , 2020-2035
    • 14.4.1. Coronary Artery Disease
    • 14.4.2. Peripheral Artery Disease
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2020-2035
    • 14.5.1. Hospitals
    • 14.5.2. Ambulatory Surgical Centers
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Material
    • 14.7.2. By Drug
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Drug-Eluting Stents Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Material, 2020-2035
    • 15.2.1. Metal
      • 15.2.1.1. Stainless-Steel
      • 15.2.1.2. Cobalt-Chromium
      • 15.2.1.3. Nitinol
      • 15.2.1.4. Others
    • 15.2.2. Polymer
      • 15.2.2.1. Non-biodegradable Polymers
      • 15.2.2.2. Biodegradable Polymers
  • 15.3. Market Value Forecast, by Drug, 2020-2035
    • 15.3.1. Sirolimus
    • 15.3.2. Paclitaxel
    • 15.3.3. Zotarolimus
    • 15.3.4. Everolimus
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Application , 2020-2035
    • 15.4.1. Coronary Artery Disease
    • 15.4.2. Peripheral Artery Disease
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2020-2035
    • 15.5.1. Hospitals
    • 15.5.2. Ambulatory Surgical Centers
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Material
    • 15.7.2. By Drug
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. AlviMedica
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. B. Braun Melsungen AG
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Biosensors International Group, Ltd.
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Shandong JW Medical Systems LTD.
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Boston Scientific Corporation
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Cook Medical Inc.
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Elixir Medical Corp.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Medtronic plc
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Eurocor GmbH
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. OrbusNeich Medical Company Limited
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Shanghai MicroPort Medical Co., Ltd.
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Sino Medical Sciences Technology Inc.
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments

List of Tables

  • Table 01: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 02: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 03: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 04: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 05: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 06: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 07: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 08: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 09: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 10: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 11: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 12: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 13: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 14: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 15: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 16: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 17: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 18: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 19: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 20: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 21: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 22: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 23: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 24: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 25: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 26: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 27: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 28: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 29: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 30: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 31: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 32: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 33: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 34: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 35: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 36: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 37: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 38: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 39: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 40: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 41: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 42: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035

List of Figures

  • Figure 01: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 03: Global Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 04: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Polymer, 2020-2035
  • Figure 05: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Metal, 2020-2035
  • Figure 06: Global Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 07: Global Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 08: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Sirolimus, 2020-2035
  • Figure 09: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Paclitaxel, 2020-2035
  • Figure 10: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Zotarolimus, 2020-2035
  • Figure 11: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Everolimus, 2020-2035
  • Figure 12: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 13: Global Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 14: Global Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 15: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Coronary Artery Disease, 2020-2035
  • Figure 16: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Peripheral Artery Disease, 2020-2035
  • Figure 17: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 18: Global Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 19: Global Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 20: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Hospital, 2020-2035
  • Figure 21: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Ambulatory Surgical Centers, 2020-2035
  • Figure 22: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 23: Global Drug-Eluting Stents Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 24: Global Drug-Eluting Stents Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 25: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 26: North America - Drug-Eluting Stents Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 27: North America - Drug-Eluting Stents Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 28: North America - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 29: North America - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 30: North America - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 31: North America - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 32: North America - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 33: North America - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 34: North America - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 35: North America - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 36: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 37: Europe - Drug-Eluting Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 38: Europe - Drug-Eluting Stents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 39: Europe - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 40: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 41: Europe - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 42: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 43: Europe - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 44: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 45: Europe - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 46: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 47: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 49: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 50: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 51: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 52: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 53: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 54: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 55: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 56: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 57: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 58: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Latin America - Drug-Eluting Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 61: Latin America - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 62: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 63: Latin America - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 64: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 65: Latin America - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 66: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 67: Latin America - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 68: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 69: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 70: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 71: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 72: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 73: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 74: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 75: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 76: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 77: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 78: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 79: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035